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Repeatability and Reproducibility of Superficial Macular
Retinal Vessel DensityMeasurements Using Optical
Coherence Tomography Angiography En Face Images
Jianqin Lei, MD; Mary K. Durbin, PhD; Yue Shi, PhD; Akihito Uji, MD, PhD; Siva Balasubramanian, MD, PhD;
Elmira Baghdasaryan, MD; Mayss Al-Sheikh, MD; Srinivas R. Sadda, MD
IMPORTANCE The repeatability and reproducibility of quantitative metrics from optical
coherence tomographic angiography (OCTA) must be assessed before these data can be
confidently interpreted in clinical research and practice.
OBJECTIVE To evaluate the repeatability and reproducibility of OCTA-derived retinal vascular
quantitative metrics.
DESIGN, SETTING AND PARTICIPANTS In this cross-sectional study, 21 healthy volunteers (42
eyes) and 22 patients with retinal disease (22 eyes), including 14 with age-relatedmacular
degeneration, 3 with epiretinal membrane, 2 with diabetic retinopathy, 2 with myopic
macular degeneration, and 1 with retinal vein occlusion, were enrolled. Participants were
recruited from September 1 through November 31, 2016. Each eye underwent 3 repeated
scans with 3 instruments for a total of 9 acquisitions. Eyes were randomly assigned to
scanning with a 3 × 3-mm or 6 × 6-mm pattern. Eyes were excluded from subsequent
analysis if any acquisition had a signal strength of less than 7. Repeatability (defined as the
agreement in measurements within a device) and reproducibility (defined as the agreement
between devices of the same type) were assessed by intraclass correlation coefficient (ICC)
and coefficient of variation.
EXPOSURES All eyes underwent scanning using 3 separate devices.
MAIN OUTCOMES ANDMEASURES Vessel length density (VLD) and perfusion density (PD) of
the superficial retinal vasculature.
RESULTS A total of 21 healthy volunteers (8men and 13 women; mean [SD] age, 36 [6] years)
and 22 patients with retinal disease (15 men and 7 women; mean [SD] age, 79 [9] years)
underwent evaluation. Of these, 40 of 42 normal eyes and 15 of 22 eyes with retinal disease
met signal strength criteria and were included in this analysis. The ICC among the 3
consecutive scans ranged from0.82 to 0.98 for VLD and from0.83 to 0.95 for PD. The
coefficient of variation (CV) ranged from 2.2% to 5.9% for VLD and from 2.4% to 5.9% for PD.
For reproducibility, the ICC ranged from0.62 to 0.95 and the CVwas less than 6% in all
groups. The agreement was highest for the 3 × 3-mm pattern in the inner ring (ICC range,
0.92 [95% CI, 0.85-0.96] to 0.96 [95% CI, 0.93-0.98]) and 6 × 6-mm pattern in the outer
ring (ICC range, 0.93 [95% CI, 0.86-0.97] to 0.96 [95% CI, 0.92-0.98]).
CONCLUSIONS AND RELEVANCE Vessel length density and PD of the superficial retinal
vasculature can be obtained fromOCTA images with high levels of repeatability and
reproducibility but can vary with scan pattern and location.
JAMA Ophthalmol. 2017;135(10):1092-1098. doi:10.1001/jamaophthalmol.2017.3431
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O ptical coherence tomography angiography (OCTA) isa rapidly evolving technology that enables noninva-sive visualization of the microvascular flow in the
retina by comparing the signal in consecutive B-scans at the
same location to reveal the motion of erythrocytes. Because
of its high-axial resolution,OCTAenables visualizationof fine
retinal vasculature inmultiple layers that isdifficult to achieve
with conventional dye-based angiography.1,2 Optical coher-
ence tomography angiography further provides an opportu-
nity to generate quantitativemetrics to describe the status of
the retinal vasculature. Optical coherence tomography angi-
ography–derived metrics described in previous reports in-
clude vessel density or perfusion density (PD),3 blood flow
index,3 skeletonized density or vessel length density (VLD),4
and fractal dimension.5
Automatic measurement tools have also been devel-
oped to generate many of these metrics.5-7 Before one can
confidently use these metrics in clinical trials or clinical
practice, establishing repeatability and reproducibility of
these measurements8 first is critical to judge whether differ-
ences between individuals or changes in these measure-
ments are of significance. Repeatability refers to agreement
of measurements from different sessions of scans using the
same device, same eye, and same operator within a short
period. Repeatability establishes the values for a margin in a
measurement over time. Reproducibility, however, refers to
agreement among different devices and operators with the
same eye within a short period. Reproducibility has particu-
lar implications for comparisons of data obtained at differ-
ent sites, for example, in the context of multicenter clinical
trials.
In thepresent study,wedetermined the repeatability and
reproducibilityof an investigationalmeasurement tool inmea-
suringVLDandPDonOCTAen face images of superficial cap-
illary plexus (SCP). We selected these specific metrics be-
cause they are provided by many OCTA commercial devices
andmay be of relevance to retinal vascular diseases.9
Methods
Study Design and Subjects
In this cross-sectional study at the Doheny UCLA Eye
Centers, we recruited 2 cohorts from September 1 to Novem-
ber 31, 2016. One cohort consisted of 42 eyes from 21 healthy
volunteers (11 white, 9 Asian, and 1 African) with no systemic
or ocular disease, as confirmedbyhistory andophthalmic ex-
amination results.Thesecondcohort consistedof22eyes from
22 patients (17 white, 2 Asian, and 1 African) with various
retinal diseases, including 8 eyes with nonneovascular age-
related macular degeneration, 6 eyes with neovascular age-
related macular degeneration, 3 eyes with epiretinal mem-
brane,2eyeswithnonproliferativediabetic retinopathy,2eyes
withmyopicmaculardegeneration, and 1eyewith central reti-
nal vein occlusion. The only requirement for the cohort with
disease was that they have media of sufficient clarity to ob-
tainOCTimaging.Written informedconsentwasobtainedfrom
all individuals before study participation. The study was ap-
proved by the institutional review board of UCLA (University
of California, Los Angeles) and conducted in accordancewith
theethical standards stated in theDeclarationofHelsinki10 and
in compliance with the regulations of the Health Insurance
Portability and Accountability Act.
Image Acquisition
Three same-model OCTA devices (AngioPlex software, ver-
sion 9.5, and Cirrus HD-OCTmodel 5000; Carl Zeiss Meditec,
Inc) were used to acquire images for this study. The enrolled
eyes underwent imaging with all 3 devices with 3 consecu-
tive scans on each device in a randomly arranged sequence,
with a total of 9 acquisitions for each eye. A different opera-
tor (3 of us: J.L., S.B., and E.B.) was assigned to each OCT
instrument. Artificial tears were not given between scans.
Two OCTA scan patterns (3 × 3-mm and 6 × 6-mm) were
evaluated in this study. For the healthy cohort, 1 eye (ran-
domly selected) was evaluated with one scan pattern and the
other eye with the second scan pattern. For the cohort with
retinal disease, only 1 eye was included as the study eye and
was randomly assigned to 1 scan pattern. The operators were
specifically trained on the study protocol and were required
to check the en face OCTA images after each acquisition to
ensure good focus, minimal saccades (identified by horizon-
tal misalignment of vessel segments on en face images), and
good centration. For an eye to be included in the final analy-
sis, a signal strength (SS) of at least 7 (maximal SS for the
AngioPlex software is a value of 10) had to be achieved across
all 9 scans.
OCTAAnalysis
All scans were analyzed using en face OCTA images gener-
ated automatically by the optical microangiography
algorithm used in the Cirrus OCTA software (AngioPlex soft-
ware, version 10.0; clearance by the US Food and Drug
Administration pending). Vessel length density (defined as
the total length of perfused vasculature per unit area in a
region of measurement) and PD (defined as the total area of
perfused vasculature per unit area in a region of measure-
ment) were measured automatically by the software that
quantified vessel density of a local region of tissue according
Key Points
Question What is the repeatability and reproducibility of
quantitative superficial macular retinal vessel density data from
optical coherence tomographic angiography?
Findings In this cross-sectional study of 21 healthy volunteers and
22 patients with retinal disease, the coefficient of variation was
less than 6% among consecutive scans and among different
devices. The agreement was highest for the 3 × 3-mm scan pattern
for the inner ring and 6 × 6-mm scan pattern for the outer ring,
and signal strength and scan pattern had a significant influence on
themeasurements.
Meaning The findings of this studymight provide useful
information for future clinical trials involving optical coherence
tomographic angiography.
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to Early Treatment of Diabetic Retinopathy Study subfields
(Figure). At present, the software only reports values for the
SCP, which is defined by the instrument to span from the
internal limiting membrane to an estimated boundary of the
inner plexiform layer. This inner plexiform layer boundary
is calculated as 70% of the distance from the internal limit-
ing membrane to an estimated boundary of the outer plexi-
form layer, which is determined as being 110 μm above the
retinal pigment epithelium boundary as automatically
detected by the software. In the present study, we evaluated
the inner ring (mean value of subfields 2 through 5) on both
scan patterns and the outer ring (mean value of subfields 6
through 9) on the 6 × 6-mm scan pattern (Figure).
Statistical Analysis
All analyseswereperformedusingSPSSsoftware (version23.0;
IBM Corporation). P < .05 indicates statistical significance.
Repeatability Analysis
Intraclass correlation coefficient (ICC) and coefficient of
variation (CV) for VLD and PD of the inner ring on both scan
patterns and the outer ring on the 6-mm pattern were calcu-
lated among the 3 consecutive acquisitions for each device.
For evaluation of the inner ring, we separated the healthy
from the cohorts with retinal disease and the 3-mm from
the 6-mm scan patterns. Independent-sample t test (com-
parison between 3- and 6-mm patterns) and paired-sample t
test (comparison between the inner and outer ring of the
6-mm pattern) were performed for comparison of CV.
Reproducibility Analysis
To test the agreement among the 3 devices, we first calcu-
lated the mean values of the 3 consecutive scans for each
device. We then calculated the ICC and CV for mean VLD
and PD among the 3 devices. This analysis was performed
for the same cohorts and locations as for the repeatability
analysis.
Predictive Factors ofMeasurement Variability
The 3 scanswithin each devicewere numbered from 1 to 3 ac-
cording to the sequenceof their acquisition time.Ageneral lin-
ear model for repeated-measurements analysis described by
Cnaan et al11 was applied for this data set to test the effect of
several candidate factors.Differentdevicesandscanswerecon-
sidered to be within-eye factors, whereas different groups
(healthy or retinal disease cohorts) and scanpattern (6 × 6- or
3 × 3-mm)were regarded as between-eye factors. The effects
of those factors on SS were also evaluated using a general
linear model.
Correlation Between SS andOCTAMeasurements
For each eye, the acquired scans were given a numerical
label from 1 to 9. The first scan in the sequence from 1 to 9
with the maximum SS and the first scan in the sequence
from 9 to 1 with the minimum SS were chosen for compari-
son. The difference in SS between these 2 extremes was
defined as the ΔSS (effectively the range of SS for that eye).
The VLDs and PDs corresponding to these maximum and
minimum SS scans were compared and the differences in
VLD and PD were termed ΔVLD and ΔPD. Pearson correla-
tion and linear regression were used to test the association
between ΔSS and ΔVLD or ΔPD.
Results
A total of 21 healthy volunteers (8 men and 13 women; mean
[SD] age, 36 [6] years) and 22 patients with retinal disease (15
men and 7 women; mean [SD] age, 79 [9] years) underwent
OCTA for this study.Among the 576OCT scan acquisitions ob-
tained, 13 (2.3%) from 9 eyes (2 normal eyes and 7 with reti-
nal disease) had an SS of less than 7. After excluding these
cases, the remaining 55 eyes (40normal eyes from20healthy
volunteers and 15 eyes with retinal disease from 15 patients)
were included in the analysis.
Figure. En Face Images of the Superficial Retinal Vasculature on Optical Coherence Tomography Angiography
6 × 6-mm Scan patternB3 × 3-mm Scan patternA
3
5
1 24
7
3
9
5
1 628 4 The optical coherence tomography
angiography image is overlaid with an
Early Treatment of Diabetic
Retinopathy Study grid. The
measurement tool (AngioPlex
software, version 10.0; Carl Zeiss
Meditec, Inc) provides vessel density
measurements in the individual
subfields (each subfield was labeled
with an arabic number) with 3 × 3-
and 6 × 6-mm scan pattern.
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Repeatability
The ICC andCVof VLD and PD among the 3 scanswithin each
device are shown inTable 1. TheCV ranged from2.2% to 5.9%
for VLD and from 2.4% to 5.9% for PD in all groups, with ICC
ranging from 0.82 to 0.98 for VLD and from 0.83 to 0.95 for
PD. Comparedwith the 3-mm inner ring, the ICC of the 6-mm
inner ring was lower (without overlapping of the 95% CI) on
device 2. The mean (SD) CV for VLD for the 6-mm outer ring
was lower than that of the 6-mm inner ring on devices 1 (3.3
[2.7] vs 2.2 [1.6];P = .009) and 3 (4.1 [4.7] vs 31. [3.3];P = .04).
The mean (SD) CV for PD was also lower in the outer ring on
device 1 (2.4 [1.7] vs 3.5 [3.7]; P = .008). The mean (SD) CV of
thehealthy cohortwas lower than that of the cohortwith reti-
nal disease for VLDondevices 1 (2.6 [1.9] vs 4.9 [3.0]; P = .02)
and 2 (2.9 [3.6] vs 5.8 [4.8]; P = .02) and PD on device 1 (2.8
[1.8] vs 4.9 [3.1]; P = .03). The ICC for VLD was higher in the
healthy cohort.
Reproducibility
The ICC and CV of VLD and PD among the 3 different ma-
chines are shown inTable 2. TheCVwas less than6% in all the
groups, and the ICC ranged from 0.62 (95% CI, 0.29-0.82) to
0.95 (95% CI, 0.91-0.98). The ICC among different machines
was lowest for the 6-mm inner ring (0.70 [95% CI, 0.43-0.85]
for VLD and 0.62 [95% CI, 0.29-0.82] for PD).
Predictive Factors forMeasurement Variability
We compared the mean VLD and PD values within the Early
Treatment of Diabetic Retinopathy Study inner ring for the
SCP in different subgroups. The estimated marginal means
(SEs) for VLD (22.6 [0.2] vs 18.2 [0.4] mm−1 for healthy cohort
and 18.2 [0.4] vs 16.7 [0.3] mm−1 for retinal disease group)
and the PD was lower (0.403 [0.004] vs 0.437 [0.005] for
healthy cohort and vs 0.343 [0.008] vs 0.405 [0.007] for reti-
nal disease cohort; P < .001) was higher for the 3-mm scan
pattern compared with the 6-mm scan pattern. The esti-
mated mean SS was also higher in the healthy group (9.8)
than in the retinal disease group (9.2; P < .001). The esti-
mated mean SS for the 3-mm and 6-mm scan types were 9.5
and 9.6, respectively (P = .61).
The effects of certain factors and their interactions on
the VLD and PD measurements are shown in Table 3. The
scan order (ie, whether the scan was the first, second, or
third obtained on a device) was observed to have an effect
on PD (F = 4.53; P = .01). Thus, a further pairwise compari-
son was performed that revealed that the PD of the first
scan was larger than that of the second (mean difference,
0.005; P = .03) and third (mean difference, 0.006; P = .005)
scans. The order of scan acquisition had no effect on VLD
(F = 2.04; P = .15).
Correlation Between SS andOutcomeMeasurements
We found a positive correlation between ΔSS and ΔVLD
(r = 0.759; P < .001) and between ΔSS and ΔPD (r = 0.698;
P < .001). Linear regression showed that the regression coef-
ficient (B) for ΔVLDwas 1.44 (95% CI, 1.10-1.78; P < .001) and
the B for ΔPD was 0.03 (95% CI, 0.02-0.04; P < .001).
Discussion
In this study, good repeatability and reproducibility were
observed for VLD and PD of the SCP obtained using the Cir-
rus AngioPlex software, version 10.0, for image analysis.
Because of the interest in using OCTA-derived quantitative
metrics in clinical trials and clinical practice, establishing
the margins of repeatability and reproducibility is impor-
tant. Reproducibility (as defined in this study) is of particu-
Table 1. Repeatability ofMeasurements onMacular Superficial Vasculature Among the 3 Scans for Each Devicea
Scan Pattern (Cohort
or No. of Eyes),
Outcome Metric
CV, Mean (SD), % ICC (95% CI)
Device 1 Device 2 Device 3 Device 1 Device 2 Device 3
3 × 3-mm, Inner ring (21 normal eyes
and 7 eyes with retinal disease)
VLD, 3.2 (2.2) 3.1 (2.9) 3.7 (2.2) 0.95 (0.91-0.98) 0.96 (0.93-0.98) 0.94 (0.89-0.97)
PD 3.2 (2.0) 3.1 (2.7) 3.6 (2.2) 0.92 (0.85-0.96) 0.94 (0.90-0.97) 0.92 (0.85-0.96)
6 × 6-mm, Inner ring (19 normal eyes
and 8 eyes with retinal disease)
VLD 3.3 (2.7) 4.2 (5.1) 4.1 (4.7) 0.92 (0.84-0.96) 0.84 (0.69-0.92) 0.90 (0.82-0.95)
PD 3.6 (2.8) 4.5 (5.7) 4.4 (5.2) 0.89 (0.80-0.95) 0.83 (0.67-0.91) 0.89 (0.80-0.95)
6 × 6-mm, Outer ring (19 normal eyes
and 8 eyes with retinal disease)
VLD 2.2 (1.6) 3.2 (3.3) 3.1 (3.3) 0.96 (0.92-0.98) 0.93 (0.88-0.97) 0.96 (0.92-0.98)
PD 2.4 (1.7) 3.5 (3.7) 3.5 (3.7) 0.95 (0.91-0.98) 0.93 (0.86-0.97) 0.95 (0.91-0.98)
21, 3 × 3-mm and 19 6 × 6-mm (Healthy cohort)
VLD 2.6 (1.9) 2.9 (3.6) 3.2 (2.2) 0.98 (0.96-0.99) 0.97 (0.95-0.98) 0.97 (0.94-0.98)
PD 2.8 (1.8) 3.1 (4.1) 3.3 (2.4) 0.89 (0.82-0.94) 0.87 (0.78-0.93) 0.92 (0.87-0.96)
7, 3 × 3-mm and 8, 6 × 6-mm
(Cohort with retinal disease)
VLD 4.9 (3.0) 5.8 (4.8) 5.9 (5.7) 0.88 (0.71-0.96) 0.82 (0.58-0.94) 0.85 (0.63-0.94)
PD 4.9 (3.1) 5.6 (5.0) 5.9 (6.2) 0.94 (0.85-0.98) 0.89 (0.75-0.96) 0.87 (0.69-0.95)
Abbreviations: CV, coefficient of variation; ICC, intraclass correlation coefficient; PD, perfusion density; VLD, vessel length density.
a See the Image Acquisition subsection of theMethods for information about these 3 devices.
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lar importance for multicenter clinical trials because mea-
surements obtained at multiple sites with different
operators and devices will be evaluated.
Repeatability has previously been reported for other
OCT devices. For the RTVue device (version 2014.2.0.65;
Optovue Inc) and its included measurement software, the
intravisit CV for PD was observed to range from 2.1% to
6.8% when measuring vessel density in different quadrants,
with ICCs ranging from 0.3 to 0.8.12 Similarly, the investiga-
tors also found that repeatability was higher in the 3-mm
scan mode. In another study of healthy participants using
the RTVue device and an automated measurement tool (An-
gioAnalytics software; Optovue),6 interoperator (only 1
device was used) agreement was 0.78 to 0.99 and intraop-
erator agreement was 0.64 to 0.93 for the SCP. Another
study13 also previously evaluated the repeatability of auto-
mated PD measurements for the RS-3000 Advance OCTA
device (Nidek). The CV for the superficial retinal layer was
5.2% with an ICC of 0.90. The investigators did not, how-
ever, assess reproducibility (between instruments and
operators) in that prior study.13 In addition, in the present
study, we observed that agreement was better for the outer
ring compared with the inner ring with the 6-mm scan pat-
tern. We suspect that precision of macular centration may
have a greater influence on the inner ring when using the
6-mm scan pattern.
Despite the relatively high level of repeatability and re-
producibility in our study, we found several factors that ap-
peared to affect VLDandPDmeasurements. For example, the
VLDandPDvalues in thecohortwith retinaldiseasewere lower
comparedwith those in thehealthycohort.Because someeyes
in the cohort with retinal disease had vascular disease, areas
of nonperfusion in those eyesmay have contributed to lower
VLDandPDinthiscohort.Thecohortwithretinaldisease,how-
ever,wasolder than thehealthycohort; this variationalsomay
have contributed to the difference.6,14 Despite the lower VLD
and PD in the disease cohort, the repeatability and reproduc-
ibilitywithin this cohort remainedgood,with aCVof less than
6%.Because relatively feweyeshadeachspecificdisease,how-
ever,wewerenot able to correlate level of reproducibilitywith
type of disease.
We also found that scan pattern had an influence on the
outcomemeasurements, although the direction of the differ-
ence varied for VLD vs PD. For VLD, the value was greater for
the 3 × 3-mm scan pattern, but it was lower for PD. This same
dichotomy was also observed in the previous study with the
RTVuedevice.11 The largerVLDswith the 3 × 3-mmscansmay
beattributable to the3 × 3-mmscanhavingbetter lateral reso-
lutionandthushaving theability todistinguishor resolvemore
capillaries. The larger PD for the 6 × 6-mm scans may be at-
tributable to the capillary size beingoverestimatedbecauseof
the lower resolution. These differences highlight the critical
need to use the same and consistent scan pattern if VLD and
PDmeasurements are comparedbetweenparticipants or over
time in the same participant.
Another factor that appeared to affect measurements in
our study was the scan order or the sequence with which
scans were obtained. This factor only had an influence on
PD. The difference in PD occurred primarily between the
first scan and the other two scans. We found no significant
difference between the second and third scans. Artificial
tears were not used between individual scan acquisitions on
a particular device in our study. Tear film instability and
some diminution of the quality of the ocular surface may
have contributed to the lower values for the second and
third scans. The estimated mean SS for the first scan (all
participants) was slightly higher (9.6) than the SS for the
second and third scans (9.5 and 9.5, respectively), but this
difference in SS was not statistically significant. Despite this
apparent difference in measurements with scan order, the
magnitude of the difference in PD was small (0.005 to
0.006), equating to a difference of less than 2%. This find-
ing could support the use of artificial tears between scans to
maximize SS and reduce another source of variability.
Table 3. Effect of Different Factors and Their Interactions
onMeasurements of VLD and PD onMacular Superficial Vasculature
Factor
Effect on VLD Effect on PD
F Value P Value F Value P Value
Device 2.98 .06 0.82 .43
Scan order (arranged
by time sequence)
2.04 .14 4.53 .01
Scan pattern (3- vs 6-mm) 96.08 <.001 62.08 <.001
Cohort (healthy
vs retinal disease)
101.70 <.001 56.90 <.001
Device × scan order 0.41 .79 0.38 .80
Device × cohort 0.30 .72 0.19 .80
Device × scan pattern 0.11 .88 0.26 .74
Abbreviations: PD, perfusion density; VLD, vessel length density.
Table 2. Reproducibility ofMeasurements onMacular Superficial
Vasculature Among the 3 Devicesa
Scan or Cohort (No. of Eyes),
Outcome Metricb ICC (95% CI)
CV,
Mean (SD), %
3 × 3-mm Inner ring (28)
VLD 0.95 (0.91-0.98) 3.6 (2.2)
PD 0.92 (0.85-0.96) 3.2 (2.2)
6 × 6-mm Inner ring (27)
VLD 0.70 (0.43-0.85) 5.0 (4.9)
PD 0.62 (0.29-0.82) 5.4 (5.1)
6 × 6-mm Outer ring (27)
VLD 0.88 (0.77-0.94) 3.7 (4.1)
PD 0.87 (0.76-0.94) 3.8 (4.3)
Healthy cohort (40)
VLD 0.95 (0.91-0.97) 3.8 (3.3)
PD 0.77 (0.60-0.87) 3.8 (3.4)
Cohort with retinal disease (15)
VLD 0.77 (0.45-0.92) 5.5 (4.9)
PD 0.83 (0.59-0.94) 5.6 (5.5)
Abbreviations: CV, coefficient of variation; ICC, intraclass correlation coefficient;
PD, perfusion density; VLD, vessel length density.
a See the Image Acquisition subsection of theMethods for information about
these 3 devices.
bDerived from themean value of the 3 acquisitions for each device.
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Another finding from our study was the influence of SS
on the quantitative measurements. Previous studies have
also suggested that quantitative metrics could be affected
by OCT SS.15,16 Gao et al17 reported that compensating for
reflectance variation would result in more reliable vessel
density quantification on OCTA. For this reason, manufac-
turers might recommend a minimum (and high) SS for OCTA
acquisitions. Despite including only high-quality (SS≥7)
scans, we observed that a difference in SS between scans
was positively correlated with a difference in VLD and PD
measurements for the whole sample. In particular, we
observed that for an SS of at least 7, if the SS increased by 1
unit, the VLD increased by 1.4 mm−1 and the PD increased
by 0.03. This finding highlights the need not only to opti-
mize SS when acquiring OCTA scans but also to maintain a
consistent SS over time. If the magnitude of this association
can be replicated in future studies, an opportunity to adjust
or correct OCTA measurements for these differences due to
SS may exist.
Limitations
Our studyhas several limitations thatmustbe considered.The
overall cohort sizes were relatively small, particularly for the
cohort with retinal disease, in which several cases had to be
excluded owing to failure to achieve manufacturer-
recommended SS for all scans. In addition, because we in-
cluded a variety of different diseases, with small numbers of
cases of individual diseases, we were not able to establish
whether the repeatability and reproducibilitywereaffectedby
the typeofdisease.This topicmaybeof interest for futurestud-
ies. Second, we focused on only the superficial retinal vascu-
lature (SCP), primarily because this was the only automated
measurement currently provided by the automated soft-
ware. The SCP may be less likely to be affected by OCTA arti-
facts, such as projection artifact, which can confound OCTA
assessments.Aprevious study13 evaluated the repeatability of
automateddeepcapillaryplexusmeasurements innormaleyes
with another OCTA device, but reproducibility still needs to
bedefined. Finally,wedidnot evaluate the reliability of other
OCTA-derivedvesselmetrics, suchas the foveal avascular zone
area and fractal dimension.
Conclusions
In this studywith a sample of 40normal eyes and 15with reti-
nal disease, we observed that automated OCTA measure-
ments (VLD and PD) of the SCP could be obtainedwith a high
level of repeatability and reproducibility using the Cirrus An-
gioPlex software (version 10.0) for 3 × 3-mm and 6 × 6-mm
scanpatterns inbothpopulations. The repeatabilitymightdif-
fer, however, based on different scan patterns and locations
(inner vs outer ring). The measurements also differed be-
tween scanpatterns andwithdifferences inSSbetween scans,
highlighting the need for consistency in acquisition proce-
dures for OCTA.
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Invited Commentary
The Arc of Change in Optical Coherence Tomographic
Angiography Technology
Progression Toward Greater Reliability
Sean T. Garrity, MD; David Sarraf, MD
The emergence of optical coherence tomographic angiogra-
phy (OCTA)hasbeenmetwith excitement, especiallywith the
opportunity to visualize detail of themicrovascularmorphol-
ogy of neovascular lesions originating from the retina
and choroid.1 However, our
initial enthusiasm has been
partially dulled by the chal-
lenges encounteredwith this
complex technology, not least of which are the struggles re-
lated to the accuracy of quantitative measurements, notably
vessel density analysis of the retinal capillaryplexus. Lei et al2
should be commended for their work in this issue of JAMA
Ophthalmology inwhich theyprovide substantivedata regard-
ing the repeatability and reproducibility of quantitativeOCTA
measurements and raise awareness of the importance of vali-
dating OCTA methods and identify potential confounders of
data acquisition and analysis.
Unlike traditional dye-based angiography systems, such
as fluorescein angiography, OCTA provides depth-resolved
quantitative microvascular assessment of the retinal capil-
lary plexus. An enormous number of studies have performed
complex quantitative analysis of the retinal capillary plexus
in normal and diseased eyes, but the validity of quantitative
OCTA analysis is sorely lacking. The report by Lei et al2 pro-
vides a much-needed validity analysis of quantitative OCTA
testing. They evaluated the repeatability of vessel lengthden-
sity (VLD) and perfusion density (PD) of the superficial reti-
nal capillary plexus with 1 OCTA instrument and the repro-
ducibility of VLD and PD between 3 identical model OCTA
instruments froma singlemanufacturer. Twenty-one normal
participants (42 eyes) and 22 participants (22 eyes) with vari-
ous retinal disorders were analyzed using 3 × 3–mm and
6 × 6–mm scan patterns. The authors reported excellent re-
peatability and reproducibility of VLD and PDmeasurements
in both normal and diseased eyes, although, as expected, va-
lidity was greater in normal eyes.
Current algorithms allow for reliable segmentation of
specific retinal vascular layers in healthy eyes, but segmenta-
tion,whetherautomaticormanual,ofpathologiceyeswithdis-
rupted retinal architecture remains challengingandcouldcon-
foundtheaccuracyofvasculardensitymeasurements.Manual
segmentation is time-consuming and is prone to intraob-
server and interobserver variability, anddistinguishingpatho-
logic vessels from normal vasculature can be difficult. Thus,
it is not surprising that Lei et al2 found greater reproducibility
and reliability in the analysis of the normal vs the disease
cohort for nearly all comparisons, although, notably, even the
disease cohort demonstratedexcellent reproducibility and re-
liability.Theauthorswerecareful to select specificdiseasepat-
terns that didnot significantly alter segmentation. This raises
concern that with certain pathologies, such as cystoid macu-
lar edema inwhich segmentation accuracy is challenging, re-
peatability and reproducibility may be lost.
Whileweareencouragedbytheveryhighrepeatabilityand
reproducibility of the study by Lei et al,2 the authors per-
formed their analysisusingan instrument fromasinglemanu-
facturer. A more advanced system is now available from the
same manufacturer and may potentially replace this system
in the near future, and continued validity analysis will be re-
quired. Optical coherence tomographic angiography instru-
mentsareavailable fromseveralmanufacturers, eachusingdif-
ferent algorithms for image acquisition, processing, and
analysis, highlighting the importanceofestablishing standard-
ized parameters, such as accepted segmentation standards.
This will be critical as data are shared, especially in the
context of global research studies and reading centers.
The effect of scan pattern remains an important and rela-
tivelyunaddressedaspectofOCTAtechnology. Lei et al2noted
differences in measurements of VLD and PD between the
3 × 3–mm and 6 × 6–mm patterns, although they did not for-
mally assess repeatability and reproducibility according to
these patterns. Reproducibilitywith 6 × 6–mmscanshas pre-
viously been shown to be less than with 3 × 3–mm patterns3
and may be attributed to insufficient pixel number across a
larger sample area. Thus, 3 × 3–mm scans may image retinal
vasculature more accurately but at the expense of a smaller
study area, illustrating the need for high-definition imaging
with larger area scans.
Perhaps themost interesting finding by Lei et al2 was the
correlation of signal strength with vessel density measure-
ments. In fact, the authors were able to identify a linear re-
gression coefficient of 1.44,2 meaning for every 1-unit differ-
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